Factors Associated with New-Onset Seizures Following Stereotac | Radiation Oncology | Articles preview

Factors Associated with New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases
https://www.advancesradonc.org/article/S2452-1094(22)00160-9/fulltext?rss=yes

Stereotactic radiosurgery (SRS) is a highly effective therapy for newly diagnosed brain metastases. Prophylactic anti-epileptic drugs are no longer routinely used in current SRS practice, owing to a perceived low overall frequency of new-onset seizures and potential side effects of medications. It is nonetheless desirable to prevent unwanted side effects following SRS. Risk factors for new-onset seizures after SRS have not been well established. As such, we aimed to characterize variables associated with increased seizure risk.